Log in to save to my catalogue

Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Diseas...

Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Diseas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_25643426

Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Disease

About this item

Full title

Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Disease

Publisher

Basel, Switzerland: Karger

Journal title

Dementia and geriatric cognitive disorders, 2012-01, Vol.33 (1), p.1-5

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: Karger

More information

Scope and Contents

Contents

Background/Aims: Biological markers of utility in tracking Alzheimer’s disease (AD) during the presymptomatic prodromal phase are important for prevention studies. Changes in cerebrospinal fluid (CSF) levels of 42-amino-acid β-amyloid (Aβ 42 ), total tau protein (t-tau) and phosphorylated tau at residue 181 (p-tau 181 ) during this state are incomp...

Alternative Titles

Full title

Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pascalfrancis_primary_25643426

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_25643426

Other Identifiers

ISSN

1420-8008

E-ISSN

1421-9824

DOI

10.1159/000335729

How to access this item